Details for New Drug Application (NDA): 210882
✉ Email this page to a colleague
The generic ingredient in SODIUM NITROPRUSSIDE is sodium nitroprusside. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Summary for 210882
Tradename: | SODIUM NITROPRUSSIDE |
Applicant: | Somerset Theraps Llc |
Ingredient: | sodium nitroprusside |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 210882
Physiological Effect | Vasodilation |
Suppliers and Packaging for NDA: 210882
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 210882 | ANDA | Somerset Therapeutics, LLC | 70069-261 | 70069-261-01 | 1 VIAL in 1 CARTON (70069-261-01) / 2 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML | ||||
Approval Date: | Aug 17, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription